Navigation Links
William Cork Joins Fenwal as Chief Technology Officer
Date:11/10/2009

LAKE ZURICH, Ill., Nov. 10 /PRNewswire/ -- Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today William H. Cork has joined the company as senior vice president and chief technology officer. Mr. Cork, 50, will lead Fenwal's research and development, regulatory and clinical affairs teams, reporting to Ron K. Labrum, Fenwal's president and chief executive officer.

Mr. Cork joins Fenwal from Northbrook, Illinois-based Nanosphere Inc. (Nasdaq: NSPH), where he was chief technology officer and vice president of research and development since 2001. Nanosphere focuses on molecular diagnostic testing.

Prior to this, Mr. Cork was vice president of research and development for Fenwal (then a division of Baxter International), where he led the development and global commercialization of platelet and cell-collection technologies, including Fenwal's Amicus and CS-3000 separator portfolios.

"Bill is a strong and experienced scientific leader, with deep knowledge of advanced molecular science, software development and transfusion medicine with clinical relationships worldwide," Labrum said. "His decade-long tenure with us in the 1990s was one of the most innovative and productive periods in Fenwal's recent history."

Mr. Cork holds more than 15 medical-technology patents and has another seven pending. He earned a bachelor's degree in electrical engineering from Northwestern University, where he also minored in biomedical engineering. Mr. Cork replaces Hiroshi Uchida as a member of Fenwal's executive team. Mr. Uchida transitioned last month to Fenwal's board of directors.

Fenwal Inc. is a global medical technology company focused on improving blood collection, separation, safety and availability for patient care. Fenwal became an independent company in 2007, but its roots go back to 1949 with the founding of Fenwal Laboratories. Fenwal developed the first flexible, disposable container for blood collection, eliminating complications associated with glass containers and allowing blood to be separated into therapeutic components. Today, the company's products and advanced collection and separation technologies are used throughout the world to help ensure a safe and available supply of lifesaving blood and blood products. Fenwal Inc. is based in Lake Zurich, Illinois. For more information, please visit www.fenwalinc.com.

SOURCE Fenwal Inc.


'/>"/>
SOURCE Fenwal Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
2. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
3. Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors
4. Dr. Derek Winstanly of Quintiles to Serve as 2009 ACRO Chair; Mr. William Sharbaugh of PPD to Be Chair-Elect
5. Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer
6. Autism Spectrum Therapies Co-Founder and Chief Clinical Officer Dr. William Frea Appointed to Board of Directors of Los Angeles Chapter of Autism Speaks
7. PAREXEL International to Present at William Blair Emerging Growth Stock Conference
8. Glamour Magazine Woman of the Year and MISSION Skincare Co-Founder, Serena Williams, Teams Up with CVS/pharmacy to Launch National Active Lifestyle Skincare Destinations
9. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
10. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
11. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... , May 6, 2016 ... of liver disorders along with rise in obesity ... drugs in the coming few years. The NASH ... last five years on account of rising number ... is a large, un-tapped market with no FDA ...
(Date:5/5/2016)... -- Replikins Ltd. today reported initial promising results in animal trials of its Zika vaccine ... ... ... ... on Pubmed. The analysis identified the highest gene Replikin Counts in Zika history back ...
(Date:5/5/2016)...  Endo International plc (NASDAQ: ENDP ... Lortie , President, U.S. Branded Pharmaceuticals, has decided ... appointment of a successor. Mr. Lortie joined Endo ... with responsibility for all strategic, commercial and operational ... development, commercial operations, managed markets, manufacturing, supply chain ...
Breaking Medicine Technology:
(Date:5/6/2016)... ... 06, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has written ... found in the Bible about helping to stop cancer. Yisrayl says there are too many ... that the health and science industries will pay close attention and take action. The Pastor ...
(Date:5/6/2016)... ... May 06, 2016 , ... Kenneth Cochran, DSc, RN, FACHE, ... of the South announced today that Dr. Robert Menuet, Interventional Cardiologist with Cardiovascular ... Ultrasound Guided Coronary Atherectomy. , This procedure involves the removal of ...
(Date:5/5/2016)... ... 2016 , ... While the practice and profession of Aging Life Care is ... has on communities and resources. Aging Life Care plays an important role as these ... , Aging Life Care is a holistic, client-centered approach to caring for older adults ...
(Date:5/5/2016)... ... 2016 , ... The U.S. Food and Drug Administration today ... submit their products through an arduous federal approval process. The rules, which treat ... market since February 15, 2007. That would essentially ban 99 percent of all ...
(Date:5/5/2016)... CA (PRWEB) , ... May 05, 2016 , ... This weekend, from Friday, May 6 ... take on steep California terrain at the first Team Semper Fi Mountain Bike Camp, hosted ... them will be mountain bike legends Mark Weir and Jason Moeschler, who’ll share pro tips ...
Breaking Medicine News(10 mins):